Zankiren

Catalog No. :
ACXYAD438
CAS No. :
138742-43-5
Molecular Formula :
C35H55N5O6S2
Molecular Weight :
705.99

IUPAC Name:(S)-2-benzyl-N-((S)-1-(((2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl)amino)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-3-((4-methylpiperazin-1-yl)sulfonyl)propanamide

Zankiren structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameZankiren
IUPAC Name(S)-2-benzyl-N-((S)-1-(((2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl)amino)-1-oxo-3-(thiazol-4-yl)propan-2-yl)-3-((4-methylpiperazin-1-yl)sulfonyl)propanamide
Molecular FormulaC35H55N5O6S2
Molecular Weight705.99
SMILESCC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC([C@H](CC2=CSC=N2)NC([C@@H](CS(=O)(N3CCN(CC3)C)=O)CC4=CC=CC=C4)=O)=O
InChI KeyYFDSDRDMDDGDFC-HOQQKOLYSA-N
SynonymZankiren;zankiren HCl;A 72517;(2S)-2-benzyl-N-[(2S)-1-[[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]amino]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]-3-(4-methylpiperazin-1-yl)sulfonylpropanamide;A 72617;4-Thiazolepropanamide, N-[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-α-[[(2S)-2-[[(4-methyl-1-piperazinyl)sulfonyl]methyl]-1-oxo-3-phenylpropyl]amino]-, (αS)-
CAS No.138742-43-5

Synthetic Route by SureRoute

1. ACXYAD438 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXYAD438 route product structure diagram
    ACXYAD438138742-43-5
Inquiry

2. ACXYAD438 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXYAD438 route product structure diagram
    ACXYAD438138742-43-5
Inquiry

Comments (0)